Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.

Using Biological Way to Deal with Your Slides

from Biology Aspect, Knowing How to Make Your Slides Clear & Attractive

Libros relacionados

Gratis con una prueba de 30 días de Scribd

Ver todo

Audiolibros relacionados

Gratis con una prueba de 30 días de Scribd

Ver todo

Using Biological Way to Deal with Your Slides

  1. 1. BIO LOGYASPECT KNOWING HOW TO DEAL WITH SLIDES CLEAR & ATTRACTIVEFROM THE
  2. 2. IF WE WANT TO KNOW MORE ABOUT LEAF A WHILE WE HAVE SOME CONTENTS TO SHARE
  3. 3. WE MIGHT PUT IT UNDER A MICRO SCOPE THE CONTENTS SHOULD BE EXTRACTED
  4. 4. IT TO SEVERAL PARTS DIVIDE DECOMPOSE YOUR CONTENTS TO SECTIONS
  5. 5. FOCUS ON A PART OF IT & GET CLOSER LOOK INSIDE EACH SECTION
  6. 6. UNTIL YOU FIND THE CORE DEFINE A CORE MESSAGE FOR EACH SECTION & ARRANGE A MESSAGE IN A SLIDE
  7. 7. THE MARVELLOUS DISCOVERY WE GET ENJOY VISUALISE THE MESSAGE WITH THE SLIDE CHEMISTRY WAY WE’VE TALKED
  8. 8. RAW DATA BIOLOGICAL DECOMPOSE IT LOOK INSIDE A MESSAGE A SLIDE VISUALISE IT T R A N S F O R M A T I O N
  9. 9. WAY TO OUR CONTENTS BIO LOGY TRY
  10. 10. The global age-standardised point prevalence of LBP (from 0 to 100 years of age) in 2010 was estimated to be 9.4% (95% CI 9.0 to 9.8). It was higher in men (mean: 10.1%; 95% CI 9.4 to 10.7) compared with women (mean: 8.7%; 95% CI 8.2 to 9.3). The age and sex distribution across regions was similar. DisMod-MR assumes a similar age pattern for all regions unless there are sufficient data points in a region to indicate a variation from the global age pattern. The large heterogeneity in the LBP dataset meant that there was no departure from the default of a common age pattern. Prevalence peaked at around 80 years of age. Age-standardised prevalence in 2010 was highest in western Europe (mean: 15.0%; 95% CI 14.1 to 16.0) followed by North Africa/Middle East (mean: 14.8%; 95% CI 13.8 to 15.9), and lowest in the Caribbean (mean: 6.5%; 95% CI 5.6 to 7.4) followed by central Latin America (mean: 6.6%; 95% CI 5.8 to 7.4). LBP Prevalence Dr Damian Hoy, University of Queensland, School of Population Health, Herston Rd, Herston, QLD 4006, Australia RAW DATA
  11. 11. The global age-standardised point prevalence of LBP (from 0 to 100 years of age) in 2010 was estimated to be 9.4% (95% CI 9.0 to 9.8). It was higher in men (mean: 10.1%; 95% CI 9.4 to 10.7) compared with women (mean: 8.7%; 95% CI 8.2 to 9.3). The age and sex distribution across regions was similar. DisMod-MR assumes a similar age pattern for all regions unless there are sufficient data points in a region to indicate a variation from the global age pattern. The large heterogeneity in the LBP dataset meant that there was no departure from the default of a common age pattern. Prevalence peaked at around 80  years of age. Age-standardised prevalence in 2010 was highest in western Europe (mean: 15.0%; 95% CI 14.1 to 16.0) followed by North Africa/Middle East (mean: 14.8%; 95% CI 13.8 to 15.9), and lowest in the Caribbean (mean: 6.5%; 95% CI 5.6 to 7.4) followed by central Latin America (mean: 6.6%; 95% CI 5.8 to 7.4). DECOMPOSE YOUR CONTENTS INTO SECTIONS
  12. 12. The global age-standardised point prevalence of LBP (from 0 to 100 years of age) in 2010 was estimated to be 9.4% (95% CI 9.0 to 9.8). It was higher in men (mean: 10.1%; 95% CI 9.4 to 10.7) compared with women (mean: 8.7%; 95% CI 8.2 to 9.3). The age and sex distribution across regions was similar. DisMod-MR assumes a similar age pattern for all regions unless there are sufficient data points in a region to indicate a variation from the global age pattern. The large heterogeneity in the LBP dataset meant that there was no departure from the default of a common age pattern. Prevalence peaked at around 80  years of age. Age-standardised prevalence in 2010 was highest in western Europe (mean: 15.0%; 95% CI 14.1 to 16.0) followed by North Africa/Middle East (mean: 14.8%; 95% CI 13.8 to 15.9), and lowest in the Caribbean (mean: 6.5%; 95% CI 5.6 to 7.4) followed by central Latin America (mean: 6.6%; 95% CI 5.8 to 7.4). LOOK INSIDE EACH SECTION TO DIG OUT THE CORE MESSAGE
  13. 13. HIGH: Western Europe is 15.0% North Africa/Middle East is 14.8% A MESSAGE A SLIDE The global point prevalence of LBP (from 0 to 100 years of age) in 2010 is 9.4% men is 10.1%, women is 8.7% LOW: Caribbean is6.5% Central Latin America is 6.6% 1 2 3
  14. 14. in 2010 (from 0 to 100 years of age) 9.4 10.1 8.7 Dr Damian Hoy, University of Queensland, School of Population Health, Herston Rd, Herston, QLD 4006, Australia PREVALENCE OF LBP GLOBAL VISUALISE IT
  15. 15. 151ST 14.8 2ND PREVALENCE OF LBP HIGH DISTRIBUTION VISUALISE IT Dr Damian Hoy, University of Queensland, School of Population Health, Herston Rd, Herston, QLD 4006, Australia
  16. 16. VISUALISE IT Dr Damian Hoy, University of Queensland, School of Population Health, Herston Rd, Herston, QLD 4006, Australia 6.5 6.6 1ST 2ND PREVALENCE OF LBP LOW DISTRIBUTION
  17. 17. BIO LOGY PRO CESS FOLLOW THE TO DO SLIDES D L A V
  18. 18. 美學行銷 Aesthetic Marketing Presentation / Infographics Coach / Analysis / Design Perpa Hsieh perpahsieh@gmail.com AESTHETIC MARKETING, perpahsieh.wix.com/amblog

×